| Chronic Lymphocytic Leukemia |
1 |
1 |
| Biologic Therapy |
0 |
0.99 |
| Leukemia |
0 |
0.83 |
| Cancer |
0 |
0.67 |
| Toxicology |
0 |
0.52 |
| Patient Safety |
0 |
0.38 |
| Bone Marrow Transplant |
0 |
0.28 |
| Stem Cell Research and Therapy |
0 |
0.25 |
| Adverse Effects |
0 |
0.22 |
| CAR-T |
0 |
0.22 |
| Statistics |
0 |
0.22 |
| Transplantation |
0 |
0.22 |
| Bone Marrow |
0 |
0.16 |
| Tyrosine Kinase Inhibitor |
0 |
0.16 |
| Healthcare and Medical Technology |
0 |
0.12 |
| Social Determinants of Health |
0 |
0.12 |
| Bone |
0 |
0.11 |
| Clinical Research |
0 |
0.11 |
| Epidemiology |
0 |
0.11 |
| Health Care Economics |
0 |
0.11 |
| Hospital |
0 |
0.11 |
| Inpatient Care |
0 |
0.11 |
| Medicaid |
0 |
0.11 |
| Medicare |
0 |
0.11 |
| Oncology Practice |
0 |
0.11 |
| Tyrosine Kinase |
0 |
0.11 |